302 – 2386 East Mall
Member Sector: Contract Research & Scientific Services
Boreal Genomics is a rapidly expanding cancer diagnostic testing company focused on circulating tumor DNA analysis from a simple blood draw.
Boreal develops and commercializes assays for pharmaceutical research, clinical research and routine clinical testing for cancer diagnostic, surveillance, and screening applications.
The assay platform has been optimized for the detection of circulating somatic mutations in plasma where cancer sequences are typically overwhelmed by normal background.
Using a novel, patented and highly selective target enrichment and sequencing method, this technology enriches cancer DNA over normal DNA a by 1,000,000-fold to allow highly multiplexed, efficient, quantitative, and sensitive mutation detection.
Boreal holds an exclusive license to a broad patent portfolio from the University of British Columbia on the company’s platform technology. The company operates with corporate headquarters in Silicon Valley, CA and an R&D site in Vancouver, Canada.